Quick Answer
MESA LABORATORIES INC /CO/ reported Total Revenue of $240.98 million for fiscal year 2025.
MESA LABORATORIES INC /CO/ — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $240.98M +11.5% |
$216.19M -1.3% |
$219.08M +18.8% |
$184.34M +37.6% |
$133.94M +13.8% |
$117.69M +14.1% |
| Revenue (ASC 606) | $240.98M +11.5% |
$216.19M -1.3% |
$219.08M +18.8% |
$184.34M +37.6% |
$133.94M +13.8% |
$117.69M +14.1% |
| Net Income | -$1.97M +99.2% |
-$254.25M -27438.3% |
$930.0K -50.3% |
$1.87M -42.9% |
$3.27M | — |
| Diluted EPS | -$0.36 +99.2% |
-$47.20 -27864.7% |
$0.17 -51.4% |
$0.35 -45.3% |
$0.64 +56.1% |
$0.41 -78.0% |
| Total Assets | $433.35M -3.0% |
$446.80M -32.5% |
$661.83M -6.4% |
$707.37M +17.6% |
$601.48M +47.0% |
$409.11M +161.0% |
| Cash and Equivalents | $27.32M -3.2% |
$28.21M -14.3% |
$32.91M -33.3% |
$49.35M -81.3% |
$263.87M +224.2% |
$81.38M +699.0% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $159.83M +9.9% |
$145.39M -63.0% |
$393.48M -0.1% |
$393.80M -3.1% |
$406.23M +84.6% |
$220.01M +97.7% |
| R&D Expense | $19.52M +1.1% |
$19.30M -5.8% |
$20.49M +30.0% |
$15.77M +51.8% |
$10.39M +63.5% |
$6.36M +81.3% |
| Operating Income | $16.34M +106.0% |
-$272.07M -8295.0% |
$3.32M -29.4% |
$4.70M -62.0% |
$12.36M +56.0% |
$7.92M -19.0% |
| Gross Profit | $150.87M +13.2% |
$133.25M -0.3% |
$133.69M +22.6% |
$109.09M +25.4% |
$87.01M +33.1% |
$65.36M +7.3% |
| Shares Outstanding | 5.46M +1.1% |
5.39M +0.5% |
5.37M +2.0% |
5.27M +2.4% |
5.14M +17.2% |
4.39M +12.8% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2025 | $65.13M | +3.6% | +7.2% |
| Revenue (ASC 606) | December 31, 2025 | $65.13M | +3.6% | +7.2% |
| Net Income | December 31, 2025 | $3.63M | +316.6% | +46.6% |
| Diluted EPS | December 31, 2025 | $0.65 | +309.7% | +44.4% |
| Total Assets | December 31, 2025 | $434.85M | +0.3% | +1.0% |
| Cash and Equivalents | December 31, 2025 | $28.98M | +6.1% | +41.9% |
| Long-Term Debt | June 30, 2019 | $17.51M | -53.5% | -15.0% |
| Stockholders Equity | December 31, 2025 | $186.69M | +20.3% | +4.6% |
| R&D Expense | December 31, 2025 | $5.03M | -0.5% | -0.4% |
| Operating Income | December 31, 2025 | $7.97M | +38.0% | +68.8% |
| Gross Profit | December 31, 2025 | $41.80M | +5.1% | +12.0% |
| Shares Outstanding | December 31, 2025 | 5.52M | +1.3% | +0.3% |
- MESA LABORATORIES INC /CO/ reported Total Revenue of $240.98 million for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed an increase of +11.5% in Total Revenue compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported Revenue (ASC 606) of $240.98 million for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed an increase of +11.5% in Revenue (ASC 606) compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported Net Income of -$1.97 million for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed an increase of +99.2% in Net Income compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported Diluted EPS of $0.36 per share (loss) for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed an increase of +99.2% in Diluted EPS compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported Total Assets of $433.35 million for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed a decrease of -3.0% in Total Assets compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported Cash and Equivalents of $27.32 million for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed a decrease of -3.2% in Cash and Equivalents compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported Long-Term Debt of $20.61 million for fiscal year 2019.
- MESA LABORATORIES INC /CO/ showed a decrease of -53.8% in Long-Term Debt compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported Stockholders Equity of $159.83 million for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed an increase of +9.9% in Stockholders Equity compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported R&D Expense of $19.52 million for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed an increase of +1.1% in R&D Expense compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported Operating Income of $16.34 million for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed an increase of +106.0% in Operating Income compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported Gross Profit of $150.87 million for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed an increase of +13.2% in Gross Profit compared to the prior fiscal year.
- MESA LABORATORIES INC /CO/ reported Shares Outstanding of 5.46 million shares for fiscal year 2025.
- MESA LABORATORIES INC /CO/ showed an increase of +1.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: